JCHO Hokkaido Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Ulcerative colitis2 trials

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Abivax S.A.2 trials
• Eli Lilly and Company1 trial
• Kowa Research Institute, Inc.1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  NCT05519475· Phase 2· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

Closed trials

• Completed

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· Phase 3· Abivax S.A.· Source

• Completed

  Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

  NCT05327127· Phase 2· Kowa Research Institute, Inc.· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

  NCT04166773· Phase 2· Eli Lilly and Company· Source